Document is current
Any future updates will be listed below
-
Authors
Szafron, Vibha
Anagnostou, Aikaterini https://orcid.org/0000-0001-6240-7437
- License Information
-
More Information
Article History
Accepted: 3 October 2022
First Online: 29 November 2022
Compliance with Ethical Standards
:
: Aikaterini Anagnostou declares PI for Aimmune Therapeutics peanut oral immunotherapy trials and receives Institutional funding, has served as Advisory Board member for DBV Technologies, all outside of the submitted work. Vibha Szafron declares no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
